Biodesix, Inc.
BDSX
$0.549
-$0.0046-0.83%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 20.43M | 18.15M | 17.93M | 14.82M | 14.67M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.43M | 18.15M | 17.93M | 14.82M | 14.67M |
| Cost of Revenue | 4.34M | 4.18M | 3.88M | 3.18M | 3.37M |
| Gross Profit | 16.09M | 13.97M | 14.05M | 11.64M | 11.29M |
| SG&A Expenses | 20.22M | 20.02M | 19.66M | 20.56M | 16.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.98M | 26.74M | 26.10M | 25.77M | 21.51M |
| Operating Income | -6.55M | -8.59M | -8.17M | -10.95M | -6.85M |
| Income Before Tax | -8.25M | -10.26M | -10.81M | -13.61M | -9.14M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.25M | -10.26M | -10.81M | -13.61M | -9.14M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.25M | -10.26M | -10.81M | -13.61M | -9.14M |
| EBIT | -6.55M | -8.59M | -8.17M | -10.95M | -6.85M |
| EBITDA | -5.10M | -7.10M | -6.76M | -9.53M | -5.87M |
| EPS Basic | -0.06 | -0.07 | -0.09 | -0.14 | -0.10 |
| Normalized Basic EPS | -0.03 | -0.04 | -0.05 | -0.09 | -0.06 |
| EPS Diluted | -0.06 | -0.07 | -0.09 | -0.14 | -0.10 |
| Normalized Diluted EPS | -0.03 | -0.04 | -0.05 | -0.09 | -0.06 |
| Average Basic Shares Outstanding | 146.60M | 146.30M | 127.17M | 97.17M | 92.33M |
| Average Diluted Shares Outstanding | 146.60M | 146.30M | 127.17M | 97.17M | 92.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |